A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin, Pulsus Group Inc
CANADIAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
The Canadian Association of Gastroenterology (CAG) Canadian Association for the Study of the Liver (CASL)

Abstract

Note: (Optional)

Citation Builder

  •  
Return to Table of Contents
 
Brief Communication September 2000, Volume 14 Issue 8: 729-731
 

A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin

Z Hassoun | B N'Guyen | J Cote | D Marleau | B Willems | A Roy | M Dagenais | R Lapointe | R Letourneau | J-P Villeneuve

A patient who underwent orthotopic liver transplantation for giant cell hepatitis with cirrhosis and in whom giant cell hepatitis recurred twice after orthotopic liver transplantation is reported. He was treated with ribavirin with an excellent result. The literature on this subject is reviewed. This observation clearly confirms the efficacy of ribavirin for the treatment of giant cell hepatitis, thus providing evidence for its viral origin.

Cirrhosis | Giant cell hepatitis | Liver failure | Orthotopic liver transplantation | Ribavirin
   Français   
          
Click to download PDF Reader
 
 




Copyright © Pulsus Group Inc.